Computed tomographic screening for lung cancer

JAMA

Volumn 308, Issue 13, 2012, Pages 1320-

  Young, Robert P ^a   Hopkins, Raewyn J ^a   Midthun, David E ^b  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RISK; CANCER SCREENING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC IMAGING; HEALTH CARE COST; HUMAN; LETTER; LUNG CANCER; PATIENT SELECTION; PRIORITY JOURNAL; RISK ASSESSMENT; LUNG TUMOR; MORTALITY; NOTE; RADIOGRAPHY;

HUMANS; LUNG NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84866888593     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/2012.jama.11892     Document Type: Letter

References (5)

1. Bach PB, Mirkin JN, Oliver TK, et al. Benefits and harms of CT screening for lung cancer: a systematic review. JAMA. 2012;307(22):2418-2429.
2. Tammemagi CM, Pinsky PF, Caporaso NE, et al. Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation. J Natl Cancer Inst. 2011;103(13):1058-1068.
3. El-Zein RA, Young RP, Hopkins RJ, Etzel CJ. Genetic predisposition to chronic obstructive pulmonary disease and/or lung cancer: important considerations when evaluating risk. Cancer Prev Res (Phila). 2012;5(4):522-527.
4. National Comprehensive Cancer Network. Guidelines on lung cancer screening. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp. Accessed August 15, 2012.
5. McMahon PM, Kong CY, Bouzan C, et al. Cost-effectiveness of computed tomography screening for lung cancer in the United States. J Thorac Oncol. 2011;6(11):1841-1848.